about
An outline of necrosome triggersInhibition of regulated cell death by cell-penetrating peptidesDeath in the fast lane: what's next for necroptosis?The intersection of cell death and inflammasome activation5-Aminolevulinic Acid-Mediated Sonodynamic Therapy Inhibits RIPK1/RIPK3-Dependent Necroptosis in THP-1-Derived Foam Cells.RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS.Inhibition of Drp1 hyper-activation is protective in animal models of experimental multiple sclerosis.The serine threonine kinase RIP3: lost and found.Development of a high throughput drug screening assay to identify compounds that protect oligodendrocyte viability and differentiation under inflammatory conditionsHSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death.ESCRT-0 dysfunction compromises autophagic degradation of protein aggregates and facilitates ER stress-mediated neurodegeneration via apoptotic and necroptotic pathways.RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4.Activation of necroptosis in human and experimental cholestasis.Pivotal Role of Receptor-Interacting Protein Kinase 1 and Mixed Lineage Kinase Domain-Like in Neuronal Cell Death Induced by the Human Neuroinvasive Coronavirus OC43.Caspase-8: not so silently deadly.Augmented trophoblast cell death in preeclampsia can proceed via ceramide-mediated necroptosisEmerging Roles for RIPK1 and RIPK3 in Pathogen-Induced Cell Death and Host Immunity.Unique spectral signatures of the nucleic acid dye acridine orange can distinguish cell death by apoptosis and necroptosis.Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.Necrosome core machinery: MLKL.Evidence of necroptosis in hearts subjected to various forms of ischemic insults.Biomarkers for the detection of necroptosis.RIPK3 Restricts Viral Pathogenesis via Cell Death-Independent Neuroinflammation.Necroptosis inhibitors as therapeutic targets in inflammation mediated disorders - a review of the current literature and patents.Mechanisms of RIPK3-induced inflammation.Roles of Caspases in Necrotic Cell Death.Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.Complex Pathologic Roles of RIPK1 and RIPK3: Moving Beyond Necroptosis.The Contribution of Necroptosis in Neurodegenerative Diseases.Necroptosis and Cancer.Initiation and execution mechanisms of necroptosis: an overview.A Comparison of Neuroimaging Abnormalities in Multiple Sclerosis, Major Depression and Chronic Fatigue Syndrome (Myalgic Encephalomyelitis): is There a Common Cause?Necroptosis in neurodegenerative diseases: a potential therapeutic target.Thioredoxin-1 actively maintains the pseudokinase MLKL in a reduced state to suppress disulfide bond-dependent MLKL polymer formation and necroptosis.Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide.Necroptosis: Mechanisms and Relevance to Disease.Necrostatin-1 attenuates early brain injury after subarachnoid hemorrhage in rats by inhibiting necroptosis.Exploitation of necroptosis for treatment of caspase-compromised cancers.Exercise leads to unfavourable cardiac remodelling and enhanced metabolic homeostasis in obese mice with cardiac and skeletal muscle autophagy deficiencyRegulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis.
P2860
Q26751108-956B0C0D-3122-4483-8E4C-81E80AF56A6CQ26751423-31013C73-3532-46C2-A819-86783C041949Q26782124-3DC01615-4E5E-40EF-AF1A-9428E072E06FQ28274739-64CA9553-F655-4333-9A25-6D3787CB0E48Q30717193-952A5AE4-C591-4324-9D20-BE3F3D5E8B19Q33728908-66D4955C-E6FC-4D32-AE2F-66AD5D5A7CF4Q33833201-EDE3A4E1-3BB6-4631-A1BE-4C0FBD6E46B3Q36082572-1ED0C260-8325-49BF-A411-6D24B25AEC5CQ36133389-87EB2F2D-EA4C-4A74-8E05-A1CCBCE1795AQ36751725-EDFC1325-A060-4C10-894D-2F020A28D08AQ36835648-1E3C1F7B-2FFB-47C6-812E-46D542410013Q37116056-74CE5B62-B623-4EEB-AFC3-B7BD4F5AF67DQ37330901-83559B6C-4E2E-45C5-87B9-2297C6309D51Q37512895-A4CA73DA-B2C1-4D37-9E02-4E23E87E05CDQ37625431-E087EEC8-017D-4F84-B549-941564AF40C8Q37745144-15A62DB8-05ED-4A25-A1C6-7892E7D0D816Q38589407-05C9A4DB-06FB-43C1-ADBD-B4985DB3B403Q38713422-348709D7-4C04-4F82-9B63-0D31C835ABC6Q38759786-B9229754-F755-4051-A4F9-9EBD0AE2A030Q38799137-964FDA3D-9C02-46F5-AA59-344B8C14B086Q38803858-F67C4976-9FC2-40CF-AEA9-CFCA4640DB7CQ38804928-17ACA57F-F42B-482B-80B1-48A661F2FC8FQ38862204-0CC4B28F-326D-43A2-AD37-1A8D04187B15Q38939282-2EDB1A34-D3BA-455C-8991-E6BE3FDDDF30Q39038663-A207906B-633C-4F0A-A866-4B8790BB1622Q39041502-25639281-44C2-4755-B41C-BFDC227BC806Q39091396-7EAD60BB-466C-4F31-BE6E-ABA9CAB116E2Q39105381-2B1C7D4A-E737-44EE-9977-73765C1236D3Q39223683-110824ED-84E8-420B-99DF-B4CBE8D54026Q39268644-0F098D64-B03D-4450-A8C7-E8B8F2D0A8D1Q39302537-BCBFB127-22F5-4658-9646-87B3215A850DQ39314274-4763D9D1-E374-43EE-9C16-4AD96166113CQ39404657-711779B4-1472-48BB-9E24-856E60256221Q40063923-597A3980-D7A3-496F-BF30-0486DE9A32D8Q40219746-FCAB2EA2-46CC-4766-8FAA-4CB543BA45DBQ40411907-4AACD393-41E5-4519-85B7-9BEC2E858337Q41018599-DA281E4E-3EE4-4881-806D-9B32EB4077E1Q41143304-5DD7205F-179E-4512-ABDA-A1B7464FB57FQ41368114-6AB17077-669D-4175-8637-F5D3CE529B58Q41527499-80CC5F24-CE54-48B1-81F2-B804E6AB60E7
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Activation of necroptosis in multiple sclerosis
@ast
Activation of necroptosis in multiple sclerosis
@en
type
label
Activation of necroptosis in multiple sclerosis
@ast
Activation of necroptosis in multiple sclerosis
@en
prefLabel
Activation of necroptosis in multiple sclerosis
@ast
Activation of necroptosis in multiple sclerosis
@en
P2093
P2860
P50
P1433
P1476
Activation of necroptosis in multiple sclerosis
@en
P2093
Ansi Chang
Bruce Trapp
Chunting Qi
Dimitry Ofengeim
Helin Vakifahmetoglu-Norberg
Jiefei Geng
Juanying Ye
Judy Park DeWitt
Junying Yuan
P2860
P304
P356
10.1016/J.CELREP.2015.02.051
P577
2015-03-01T00:00:00Z